This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of various bioactive molecules. Its chiral structure makes it valuable in the development of enantiomerically pure drugs, particularly those targeting neurological and cardiovascular disorders. The presence of the benzyl and methoxy groups enhances its ability to interact with specific biological receptors, making it a key component in the design of receptor modulators and enzyme inhibitors. Additionally, it is employed in research settings to study the structure-activity relationships of compounds with similar scaffolds, aiding in the discovery of new therapeutic agents.